Association of diabetes risk reduction diet (DRRD) score with metabolic health, brain-derived neurotrophic factor and adropin in Iranian adults Authors: Alireza Rashki, Zahra Moradmand, Farnaz Shahdadian, Parisa Rouhani, Parvane Saneei Published: 2025 ABSTRACT BackgroundThe connection between the diabetes risk reduction diet (DRRD) score and metabolic health is not exactly clear. This study examined the association between DRRD score and metabolic health (MH), serum adropin, and brain-derived neurotrophic factor (BDNF) in Iranian adults.MethodsThis cross-sectional investigation employed a sample of 527 adults (45.7% females) within the age range of 20 to 65 years, who were selected via a multistage cluster random sampling technique. Dietary assessment of participants was evaluated utilizing a validated food frequency questionnaire, while a fasting blood sample from each participant was procured to analyze biochemical parameters. MH status was ascertained according to the criteria delineated by Wildman et al. The DRRD score was calculated based on nine elements.ResultsAfter adjusting for potential confounders, no significant association was observed between higher DRRD score tertiles and odds of metabolically unhealthy status (OR = 0.99; 95% CI: 0.58–1.70). Individuals in the highest tertile of DRRD score demonstrated a 44% (95% CI: 0.33–0.96) significant reduction in the odds of developing hypertriglyceridemia compared to those in the lowest tertile. However, no significant reduction was observed in other Metabolically Unhealthy (MU) components. Also, no significant difference was observed in BDNF and adropin levels among individuals in DRRD score tertiles.ConclusionsA Higher DRRD score was associated with reduced odds of hypertriglyceridemia, but no significant associations were observed with other metabolic unhealthy components or BDNF and adropin levels. Introduction Obesity is a multifaceted condition that raises susceptibility to prevalent non-communicable chronic illnesses [1]. Prevalence of obesity on a global scale has exhibited a notable upsurge since 1980, resulting in approximately one-third of the global population being affected by overweight and obesity, and this indicates a significant increase in health and financial challenges [2, 3]. The term “metabolically healthy” (MH) refers to individuals who do not exhibit metabolic disorders, which encompass conditions such as hypertension, specific types of dyslipidemia characterized by low levels of high-density lipoprotein (HDL) cholesterol and/or hypertriglyceridemia, as well as Insulin Resistance (IR) [4]. The exact mechanisms of metabolic disease incidence are complex, but genetic, environmental, and dietary factors are known to be contributors, and it is widely accepted that individuals who exhibit an MH phenotype have a lower risk of developing non-communicable diseases (NCDs), like diabetes mellitus, cardiovascular diseases (CVDs), and certain cancers. The increased risk for these illnesses persists even among individuals with a normal weight who display a metabolically unhealthy (MU) phenotype [5]. Multiple epidemiological studies have provided compelling evidence regarding the significant contributions of genetic and environmental factors, particularly dietary intake, to the development of MU [6]. Previous research has demonstrated that adhering to a nutritious, well-balanced diet has a significant effect on preventing the progression from an MH state to a MU state. On the other hand, adopting unhealthy eating patterns has been found to increase the risk of developing NCDs and inflammation [7]. Numerous epidemiological investigations have explored the association between dietary patterns and susceptibility to chronic illnesses. The Diabetes Risk Reduction Diet (DRRD) score, a dietary pattern score, has demonstrated effectiveness in preventing certain conditions [8]. Such a dietary pattern could serve as a valuable tool for comparing the dietary intake across various populations. This pattern represents a blend of various nutrients that have the potential to be identified for their likely collaborative impacts and interrelations [9]. Some past studies have investigated and documented inverse relationships between DRRD and Dietary Diabetes Risk Reduction score (DDRRS) and various diseases, such as type II diabetes and some types of cancer (including breast and renal cancer), as well as metabolic complications in adults [10–17]. Conversely, no significant association was observed between a higher DDRR score and the incidence of cardiovascular disease (CVD) [18]. A study revealed a negative correlation between DRRD score and the percentage of body fat, visceral fat area (VFA), serum triglyceride, and insulin levels in overweight and obese women [19]. Also, some past studies have shown an effective relationship between compliance with DRRDs and DDRRS and metabolic syndrome (MetS) [20, 21]. In recent years, there has been a growing emphasis placed on the importance of biomarkers, specifically brain-derived neurotrophic factor (BDNF) and adropin, in the context of metabolism. Prior studies have indicated a negative relationship between these biomarkers and specific metabolic abnormalities such as IR and dyslipidemia. This connection can be ascribed to the role of these biomarkers in energy homeostasis and insulin reactivity [22, 23]. Moreover, new research suggested that dietary consumption and other behavioral elements might influence the plasma concentrations of these biomarkers [24, 25]. Also, the results of some studies showed that following dietary patterns could have an impact on the levels of these biomarkers [26, 27]. Drawing upon previous research, it was postulated that BDNF and adropin could conceivably serve as mediators in the relationship between diet and metabolic health status. To our current understanding, there is no known previous research that has evaluated the link between DRRD score status and MH/MU status among adults, especially among Iranian adults. Therefore, our cross-sectional study aimed to examine the association between DRRD score and odds of MU and the status of BDNF and adropin levels as mediators in this relationship in an Iranian adult population. Methods and materials Study design and population This study was conducted in 2021, focusing on a sample of Iranian individuals residing in Isfahan, Iran. The selection of participants for this study was carried out using a multistage random-sampling technique [28]. To be more specific, adult individuals who were employed as educators, school administrators, staff members, crews, aides, or personnel in educational institutions located in different districts of Isfahan were included. This population was selected to have a sample of adults with different socioeconomic levels, besides considering their high accessibility and willingness to cooperate in research. In accordance with recent statistical data, it appears that around 49.4% of the adult population in Iran may potentially manifest metabolic dysfunctions [29]. Considering this rate, besides a type 1 error rate of 0.05, a confidence interval (95% CI) of 0.95, a precision (d) of 4.5%, and a power of 80%, a minimum sample size of 474 individuals was determined for this study. Due to challenges posed by the COVID-19 pandemic and its impact on data collection, a total of 600 individuals were invited to participate in the investigation. The response rate observed for the study was documented as 90.5%. Individuals meeting the following criteria were nor eligible for this investigation: [1] a medical history of type 1 diabetes, cardiovascular diseases, stroke, or cancer; [2] pregnant or breastfeeding individuals; [3] following a specialized dietary plan (diets designed for therapeutic, medical, or performance-related purposes, such as the ketogenic diet, prescribed weight-loss diets, or diets tailored for specific medical conditions). The exclusion criteria for the study consisted of three main factors. Firstly, participants who left more than 70 items on the food frequency questionnaire (FFQ) unfilled were excluded (n = 4). Secondly, individuals who reported an energy intake less than 800 kcal/day or more than 4200 kcal/day were also excluded from the study (n = 3) [30]. Lastly, participants who declined to undergo a blood draw were also excluded from the analysis (n = 9). In total, 527 individuals ranging in age from 20 to 65 were determined to be eligible for inclusion in this survey. All participants willingly provided their written consent after receiving complete and comprehensive information. The research protocol for this study has received official approval from the Local Ethics Committee of Isfahan Medical Sciences. Assessment of dietary intakes The participants’ dietary intakes were evaluated using a Willett-format semi-quantitative 168-item FFQ. The questionnaire’s efficacy has been confirmed through a prior validation study, which demonstrated noteworthy correlations between the food intakes obtained from this questionnaire and the data gathered from multiple 24-hour dietary recalls [31]. Each participant in the study received guidance from a certified nutrition professional to complete the FFQ. The FFQ required participants to document the frequency and amount of food consumed over the course of the preceding year. Subsequently, the recorded measurements were converted into grams per day using commonly used household measurements [32]. Then, all food items were input into the Nutritionist IV software to calculate daily energy and nutritional values. Construction of DRRD score Upon previous understanding of the correlation between different dietary components and diabetes, the DRRD score was developed utilizing information from previously documented studies [33]. Nine dietary components, including cereal fiber, nuts, caffeine, whole fruits, ratio of polyunsaturated fat to saturated fat, glycemic index (GI), trans fats, sugar-sweetened beverages (SSBs) and fruit juices, as well as red and processed meats, were taken into account within the framework of this evaluation methodology. In this study, participants were categorized into quintiles based on various above-mentioned components. The components that were previously found to have protective effects against diabetes in other research studies were cereal fiber, nuts, coffee (both caffeinated and decaffeinated) whole fruits (such as raisins, prunes, bananas, cantaloupes, watermelon, fresh apples/pears, oranges, grapefruits, strawberries, blueberries, peaches/apricots/plums), and ratio of polyunsaturated fat to saturated fat. For each of these food items, participants were assigned a score based on their quintile ranking. Specifically, individuals who were in the highest quintile for these food items or nutrients were given a score of 5, while those in quintiles 1, 2, 3, and 4 were assigned scores of 1, 2, 3, and 4, respectively. For nutrients and food groups linked to unfavorable outcomes in terms of diabetes risk, such as glycemic index, trans fats, SSBs/fruit juices (including apples, oranges, grapefruits, and other varieties of fruit juices), as well as red and processed meats, we adopted a contrasting approach. Specifically, individuals placed in the highest quintile were assigned a score of 1, while those in the lowest quintile were allocated a score of 5. Likewise, participants in quintiles 2, 3, and 4 received scores of 4, 3, and 2, respectively. Then, an overall DRRD score was calculated by summing the scores obtained by each participant across all nine components. This composite score ranged from 5 to 45 [33]. Assessment of anthropometric indices and blood pressure Weight, height, and waist circumference (WC) measurements were performed by two experienced dietitians (women were evaluated by a female dietitian and men were evaluated by a male dietitian, due to cultural and religious considerations). Participants were asked to remove any excess clothing and footwear for these assessments. Weight was determined using the Tanita MC-780MA body composition analyzer from Tokyo, Japan, which has a precision of 0.1 kg. Height was measured utilizing a wall-mounted tape measure, ensuring an accuracy of 0.1 cm. Body mass index (BMI) was then calculated by dividing the weight by the square of the height (m2). WC was evaluated using a non-stretched tape measure, with measurements being rounded to the nearest 0.1 cm. Blood pressure (BP) was determined using a digital sphygmomanometer (OMRON, M3, HEM-7154-E, Japan), which had a precision of 0.5 mmHg. Before measuring BP, participants were seated for five minutes with no preceding physical activity and an empty bladder. Two separate occasions were utilized for BP measurements, with time intervals ranging from 5 to 10 min. The average of these measurements was subsequently recorded as the final blood pressure value. Assessment of biochemical parameters A 10-mL blood sample was collected from the peripheral of each participant, after a 12-hour fasting period. The Biosystem A15 auto-analyzer was employed to quantify specific biochemical parameters using enzymatic colorimetric methods. These parameters included the concentration of triglycerides (TG), which was determined using the glycerol phosphate oxidase (GPO) method, the measurement of fasting blood glucose (FBG) using the glucose oxidase (GOD) method, and the assessment of HDL-c using the cholesterol oxidase (CHOD) method. Additional serum parameters were evaluated using commercially available enzyme-linked immunosorbent assay (ELISA) kits. These parameters encompassed high-sensitive C-reactive protein (hs-CRP), which was quantified through a turbidimetry kit and a latex-enhanced turbidimetric method known as Delta.DP. Insulin measurement was performed using Monobined Inc. (Lake Forest, CA 92630, USA). In order to assess the levels of BDNF and adropin, commercially available kits obtained from Zellbio, located in Veltlinerweg, Germany, were utilized. Meanwhile, the degree of IR was evaluated by employing the Homeostasis Model Assessment Insulin Resistance (HOMA-IR) equation. This equation involves the calculation of HOMA-IR through a formula [FBG (mmol/L) × fasting insulin (mU/L)]/22.5 [34]. Zellbio GmbH ELISA kit was used for the quantitative assay of human BDNF and adropin on the basis of the biotin double antibody sandwich technology. The assay range of adropin ranged from 30 to 960 pg/mL with 4 pg/mL sensitivity; the intra-assay and inter-assay CV were < 10 and < 12%, respectively. For BDNF, the assay range was 0.04 to 12.8 ng/mL with a sensitivity of 0.05 ng/mL; the intra-assay and inter-assay CV were < 10 and < 12%, respectively. Assessment of metabolic health status The Metabolic health of participants was evaluated using the criteria established by Wildman et al. [35]. According to this defined criteria, individuals who displayed two or more than two of the following risk factors were classified as MU: [1] fasting blood glucose levels of 100/dL or higher; [2] low levels of HDL-c, as less than 40 mg/dL for males or less than 50 mg/dL for females; [3] elevated levels of triglycerides, defined as 150 mg/dL or higher; [4] hypertension, indicated by BP of 130/85 mmHg or higher; [5] insulin resistance, determined by HOMA-IR value higher than the 90th percentile (or greater than 3.99 in the present study); and [6] elevated levels of the inflammatory protein hs-CRP, defined as above the 90th percentile (or exceeding 6.14 mg/L in the present study). On the other hand, individuals categorized as MH did not meet ≥ 2 of the aforementioned disorders. Assessment of other variables Socio-demographic information, including sex, age, marital status, level of education, and smoking habits, was gathered through the use of a self-administered questionnaire. To evaluate the socioeconomic status (SES) of the participants, a validated questionnaire was utilized [36]. The objective of this questionnaire was to assess individuals based on various factors, including their family size, homeownership status, car ownership, possession of laptops or computers, and travel experiences within the past year. Physical activity levels were measured using a well-established tool called the International Physical Activity Questionnaire-short form (IPAQ-SF). This specific instrument has been developed with the purpose of assessing and quantifying three specific domains of physical activity: walking, moderate-intensity activities, and vigorous-intensity activities [37]. The information gathered from this survey has been converted into Metabolic Equivalent Task minutes per week (MET. min/week), enabling us to classify individuals into three categories: inactive (< 600 MET. min/week), minimally active (≥ 600 to < 3000 MET. min/week), and health enhancing physical activity (HEPA) active (≥ 3000 MET. min/week) [38]. Statistical analysis Energy-adjusted intake of components of the DRRD score was estimated using the residual method. Subsequently, participants were divided into groups based on tertiles of energy-adjusted DRRD score. Continuous variables were presented as mean ± standard deviation (SD) or standard error (SE), while categorical variables were expressed as a percentage. One-way analysis of variance (ANOVA) and chi-square tests were utilized to compare characteristics of subjects across tertiles of energy-adjusted DRRD score. Dietary intakes of individuals were assessed through analysis of covariance (ANCOVA), with adjustments made for sex, age, and energy intake. Furthermore, potential associations between the DRRD score with MU status, and all components of MU were examined using binary logistic regression. The analyses were conducted while accounting for the effects of potential confounders. In the first model, age, sex, and energy intake were controlled for. In the second model, additional socio-demographic variables such as education, marital status, smoking status, SES, and physical activity categories were also considered. Lastly, to examine the relationship independent of obesity, BMI was additionally considered as a confounding variable. Tertiles of energy-adjusted DRRD score were treated as an ordinal variable in logistic regression models to compute P for trend. ANOVA and ANCOVA were applied to assess the mean values of serum adropin and BDNF among tertiles of DRRD score. For BDNF, the confounding effects of age, sex, physical activity, high BP, TG, and FBG were taken into account. For adropin, the confounding effects of age, sex, energy intake, physical activity, and BMI were considered. All statistical analyses were conducted using SPSS software version 26 (IBM, Chicago, IL). In the current cross-sectional study, P-values < 0.05 were considered statistically significant. Results This study included a group of 527 participants; 45.7% of them were female. The average age of the participants was 42.66 years (± 11.19 SD). The average recorded weight was 75.77 kg (± 14.59 SD), and the BMI of these participants was between 16.60 and 59.80 kg/m². Based on Wildman et al. criteria, 42.5% of participants were classified as metabolically unhealthy. Within this population, 20.5% were classified as normal weight, while 79.5% were classified as overweight or obese. The average serum BDNF and adropin concentration in study participants was 1.25 ng/mL and 56.58 pg/mL, respectively. General characteristics and cardiometabolic factors of study participants across tertiles of DRRD score are shown in Table 1. On average, participants in the highest tertile were older and a higher proportion of females compared to those in the lowest tertile. Nevertheless, no substantial differences were found in other demographic or cardiovascular risk factors across the tertiles. Table 1General characteristics and cardiometabolic factors of study participants across tertiles of DRRD score1DRRD score tertilesTertile 1(n = 190)(score of 15–25)Tertile 2(n = 146)(26–28)Tertile 3(n = 191)(29–39)P-value2Age, year39.75\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.2542.82\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.2145.41\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.41< 0.001Sex, (%)0.04 Males57.958.947.1 Females42.141.152.9Marital status, (%)0.43 Single, divorced, or widow15.420.817.4 Married84.679.282.6Metabolic health status, (%)0.48 Healthy60.557.554.5 Unhealthy39.542.545.5Education status, (%)0.99 Diploma or lower11.11111.1 Higher than diploma88.98988.9Home ownership, (%)0.22 Owner70.776.878.1 Tenant29.323.221.9Family size, (%)0.24 >4 members12.213.118.0 ≤ 4 members87.886.982.0Weight (kg)76.46\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}14.6075.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}13.6275.06\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}15.300.64BMI (kg/m2)26.83\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.2526.82\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.0627.05\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.860.85Waist circumference (cm)92.93\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.7792.40\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.5192.58\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.970.90Smoking, (%)0.45 Non-smoker94.391.794.4 Ex-smoker1.75.33.1 Current smoker4.03.02.5Physical activity levels, (%)0.47 Inactive57.757.555.0 Minimally active37.032.236.5 HEPA active5.310.38.5Systolic blood pressure (mmHg)120.59\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}14.63121.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}15.18122.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}17.630.33Diastolic blood pressure (mmHg)81.63\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}9.9382.27\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}8.8183.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.280.08Fasting blood glucose (mg/dL)90.24\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}13.1693.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}20.7693.57\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}21.800.16Triglycerides (mg/dL)154.47\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}39.19157.06\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}45.09149.09\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}38.710.18HDL-c (mg/dL)54.71\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.4154.94\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}9.1356.39\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.130.21hs-CRP (> 90th percentile)3.15\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.093.58\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.242.90\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.400.10HOMA-IR index (> 90th percentile)1.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.631.38\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.181.64\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.430.29HEPA Health enhancing physical activity1Values are Mean ± SD; unless indicated2Obtained from one-way ANOVA and χ2 test for quantitative and categorical variables, respectively Table 1General characteristics and cardiometabolic factors of study participants across tertiles of DRRD score1DRRD score tertilesTertile 1(n = 190)(score of 15–25)Tertile 2(n = 146)(26–28)Tertile 3(n = 191)(29–39)P-value2Age, year39.75\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.2542.82\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.2145.41\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.41< 0.001Sex, (%)0.04 Males57.958.947.1 Females42.141.152.9Marital status, (%)0.43 Single, divorced, or widow15.420.817.4 Married84.679.282.6Metabolic health status, (%)0.48 Healthy60.557.554.5 Unhealthy39.542.545.5Education status, (%)0.99 Diploma or lower11.11111.1 Higher than diploma88.98988.9Home ownership, (%)0.22 Owner70.776.878.1 Tenant29.323.221.9Family size, (%)0.24 >4 members12.213.118.0 ≤ 4 members87.886.982.0Weight (kg)76.46\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}14.6075.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}13.6275.06\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}15.300.64BMI (kg/m2)26.83\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.2526.82\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.0627.05\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}4.860.85Waist circumference (cm)92.93\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.7792.40\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.5192.58\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.970.90Smoking, (%)0.45 Non-smoker94.391.794.4 Ex-smoker1.75.33.1 Current smoker4.03.02.5Physical activity levels, (%)0.47 Inactive57.757.555.0 Minimally active37.032.236.5 HEPA active5.310.38.5Systolic blood pressure (mmHg)120.59\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}14.63121.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}15.18122.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}17.630.33Diastolic blood pressure (mmHg)81.63\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}9.9382.27\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}8.8183.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.280.08Fasting blood glucose (mg/dL)90.24\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}13.1693.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}20.7693.57\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}21.800.16Triglycerides (mg/dL)154.47\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}39.19157.06\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}45.09149.09\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}38.710.18HDL-c (mg/dL)54.71\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.4154.94\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}9.1356.39\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.130.21hs-CRP (> 90th percentile)3.15\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.093.58\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.242.90\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.400.10HOMA-IR index (> 90th percentile)1.80\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.631.38\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.181.64\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.430.29HEPA Health enhancing physical activity1Values are Mean ± SD; unless indicated2Obtained from one-way ANOVA and χ2 test for quantitative and categorical variables, respectively General characteristics and cardiometabolic factors of study participants across tertiles of DRRD score1 HEPA Health enhancing physical activity 1Values are Mean ± SD; unless indicated 2Obtained from one-way ANOVA and χ2 test for quantitative and categorical variables, respectively Dietary intakes, including energy, macro/micro nutrients, and food groups of study participants across tertiles of DRRD score are presented in Table 2. Individuals in the highest tertile of DRRD score exhibited significantly higher intake of energy, carbohydrates, fiber, cereal fiber, fruits, caffeine, nuts, PUFA/SFA ratio, and lower intake of protein, total fat, glycemic index, SSB and fruit juice, red and processed meats compared to those in the lowest tertile. Table 2Dietary intakes (energy, macro/micro nutrients, and food groups) of study participants across tertiles of DRRD score1DRRD score tertilesTertile 1(n = 190)(score of 15–25)Tertile 2(n = 146)(26–28)Tertile 3(n = 191)(29–39)P-value2Energy, kcal2194.15\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}49.422213.99\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}55.602407.49\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}49.420.005Protein, % of energy15.22\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.2014.09\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.2213.39\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.20< 0.001Carbohydrate, % of energy58.52\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5860.64\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.6563.47\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.58< 0.001Fat, % of energy27.85\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.4827.21\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5425.44\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.480.002Fiber, g/d19.29\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.4520.86\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5123.25\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.45< 0.001Cereal fiber, g/d3.05\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.113.38\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.123.60\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.110.004Nuts, g/d7.93\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.9012.07\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:1$$\end{document}.0115.53\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.90< 0.001Caffeine, mg/d95.81\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.97152.18\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}12.32198.01\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.01< 0.001Whole fruits, g/d484.30\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}22.55489.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}25.34576.52\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}22.640.008PUFA to SFA ratio0.56\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.020.78\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.020.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.02< 0.001Glycemic index59.92\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.3358.73\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.3757.73\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.33< 0.001SSBs and fruit juices, g/d94.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}7.2877.88\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}8.1838.49\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}7.31< 0.001Red and processed meats, g/d93.89\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.9563.68\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.3243.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.96< 0.0011Values are Mean ± SE. Energy intake and macronutrients were adjusted for age and sex; all other values were adjusted for age, sex, and energy intake2P-value obtained from ANCOVA Table 2Dietary intakes (energy, macro/micro nutrients, and food groups) of study participants across tertiles of DRRD score1DRRD score tertilesTertile 1(n = 190)(score of 15–25)Tertile 2(n = 146)(26–28)Tertile 3(n = 191)(29–39)P-value2Energy, kcal2194.15\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}49.422213.99\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}55.602407.49\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}49.420.005Protein, % of energy15.22\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.2014.09\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.2213.39\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.20< 0.001Carbohydrate, % of energy58.52\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5860.64\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.6563.47\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.58< 0.001Fat, % of energy27.85\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.4827.21\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5425.44\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.480.002Fiber, g/d19.29\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.4520.86\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.5123.25\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.45< 0.001Cereal fiber, g/d3.05\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.113.38\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.123.60\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.110.004Nuts, g/d7.93\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.9012.07\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:1$$\end{document}.0115.53\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.90< 0.001Caffeine, mg/d95.81\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}10.97152.18\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}12.32198.01\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}11.01< 0.001Whole fruits, g/d484.30\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}22.55489.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}25.34576.52\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}22.640.008PUFA to SFA ratio0.56\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.020.78\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.020.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.02< 0.001Glycemic index59.92\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.3358.73\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.3757.73\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}0.33< 0.001SSBs and fruit juices, g/d94.32\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}7.2877.88\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}8.1838.49\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}7.31< 0.001Red and processed meats, g/d93.89\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.9563.68\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}3.3243.96\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:$$\end{document}2.96< 0.0011Values are Mean ± SE. Energy intake and macronutrients were adjusted for age and sex; all other values were adjusted for age, sex, and energy intake2P-value obtained from ANCOVA Dietary intakes (energy, macro/micro nutrients, and food groups) of study participants across tertiles of DRRD score1 1Values are Mean ± SE. Energy intake and macronutrients were adjusted for age and sex; all other values were adjusted for age, sex, and energy intake 2P-value obtained from ANCOVA Multivariable adjusted odds ratio (OR) and 95% confidence interval (95% CI) for metabolically unhealthy status across tertiles of DRRD score are shown in Table 3. After control of potential variables, individuals in the highest DRRD score tertile showed no significant change for odds of MU compared to the lowest tertile (OR = 0.99; 95% CI: 0.58–1.70). Also, no significant association was observed between a 1-score increase in DRRD score tertiles and the likelihood of MU. Similarly, each 1-tertile increase showed no statistically significant association with MU.Table 3Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolically unhealthy status across tertiles of DRRD score1DRRD score tertilesTertile 1 (n= 190) (score of 15–25)Tertile 2 (n= 146) (26–28)Tertile 3 (n= 191) (29–39)P-trendPer 1 score increasePer 1 tertile increaseCases/Participants (n)75/19062/14687/191Crude11.13 (0.73–1.75.73.75)1.28 (0.85–1.92.85.92)0.231.03 (0.99–1.07.99.07)1.13 (0.92–1.38.92.38)Model 1210.94 (0.59–1.51.59.51)0.99 (0.63–1.55.63.55)0.971.00 (0.95–1.05.95.05)0.99 (0.79–1.24.79.24)Model 2310.79 (0.46–1.34.46.34)0.92 (0.55–1.55.55.55)0.761.00 (0.94–1.05.94.05)0.96 (0.74–1.24.74.24)Model 3410.79 (0.45–1.37.45.37)0.99 (0.58–1.70.58.70)0.971.01 (0.95–1.07.95.07)0.99 (0.76–1.30.76.30)1 All values are odds ratios and 95% confidence intervals2 Model 1: Adjusted for age, sex, and total energy intake3 Model 2: Additionally adjusted for physical activity, smoking, marital status, educational status, and socioeconomic status4 Model 3: Further adjusted for BMI Table 3Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolically unhealthy status across tertiles of DRRD score1DRRD score tertilesTertile 1 (n= 190) (score of 15–25)Tertile 2 (n= 146) (26–28)Tertile 3 (n= 191) (29–39)P-trendPer 1 score increasePer 1 tertile increaseCases/Participants (n)75/19062/14687/191Crude11.13 (0.73–1.75.73.75)1.28 (0.85–1.92.85.92)0.231.03 (0.99–1.07.99.07)1.13 (0.92–1.38.92.38)Model 1210.94 (0.59–1.51.59.51)0.99 (0.63–1.55.63.55)0.971.00 (0.95–1.05.95.05)0.99 (0.79–1.24.79.24)Model 2310.79 (0.46–1.34.46.34)0.92 (0.55–1.55.55.55)0.761.00 (0.94–1.05.94.05)0.96 (0.74–1.24.74.24)Model 3410.79 (0.45–1.37.45.37)0.99 (0.58–1.70.58.70)0.971.01 (0.95–1.07.95.07)0.99 (0.76–1.30.76.30)1 All values are odds ratios and 95% confidence intervals2 Model 1: Adjusted for age, sex, and total energy intake3 Model 2: Additionally adjusted for physical activity, smoking, marital status, educational status, and socioeconomic status4 Model 3: Further adjusted for BMI Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolically unhealthy status across tertiles of DRRD score1 1 All values are odds ratios and 95% confidence intervals 2 Model 1: Adjusted for age, sex, and total energy intake 3 Model 2: Additionally adjusted for physical activity, smoking, marital status, educational status, and socioeconomic status 4 Model 3: Further adjusted for BMI Multivariable adjusted odds ratio (OR) and 95% confidence interval (95% CI) for metabolic components across tertiles of DRRD score are presented in Table 4. After adjusting for confounding factors, individuals in the highest tertile of DRRD score demonstrated a 44% (OR = 0.56; 95% CI: 0.33–0.96) significant reduction in odds of developing hypertriglyceridemia compared to those in the lowest tertile. No other significant association was found between different DRRD score levels and increased levels of hs-CRP, fasting blood glucose, HOMA-IR, blood pressure, and decreased levels of HDL-c.Table 4Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolic components across tertiles of DRRD score1DRRD score tertilesTertile 1(n= 190)(score of 15–25)Tertile 2(n= 146)(26–28)Tertile 3(n= 191)(29–39)P-trendHigh hs-CRP Crude11.25 (0.62–2.53.62.53)0.93 (0.46–1.87.46.87)0.85 Fully-adjusted model210.71 (0.32–1.59.32.59)0.55 (0.24–1.24.24.24)0.15High fasting blood glucose Crude11.27 (0.72–2.22.72.22)1.53 (0.92–2.56.92.56)0.10 Fully-adjusted model210.99 (0.50–1.93.50.93)1.00 (0.52–1.93.52.93)0.98High triglyceride Crude11.12 (0.72–1.74.72.74)0.68 (0.44–1.04.44.04)0.08 Fully-adjusted model211.00 (0.59–1.68.59.68)0.56 (0.33–0.96.33.96)0.04Low HDL-c Crude10.92 (0.45–1.85.45.85)1.21 (0.65–2.24.65.24)0.53 Fully-adjusted model210.69 (0.29–1.64.29.64)1.41 (0.66–3.02.66.02)0.37High HOMA-IR Crude10.68 (0.32–1.43.32.43)0.79 (0.41–1.53.41.53)0.48 Fully-adjusted model210.70 (0.31–1.59.31.59)0.80 (0.36–1.79.36.79)0.58High blood pressure Crude11.34 (0.86–2.07.86.07)1.79 (1.19–2.69.19.69)0.01 Fully-adjusted model211.07 (0.62–1.84.62.84)1.57 (0.92–2.68.92.68)0.10 1All values are odds ratios and 95% confidence intervals2Fully-adjusted model: Adjusted for age, sex, total energy intake, physical activity, smoking, marital status, educational status, socioeconomic status, BMI Table 4Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolic components across tertiles of DRRD score1DRRD score tertilesTertile 1(n= 190)(score of 15–25)Tertile 2(n= 146)(26–28)Tertile 3(n= 191)(29–39)P-trendHigh hs-CRP Crude11.25 (0.62–2.53.62.53)0.93 (0.46–1.87.46.87)0.85 Fully-adjusted model210.71 (0.32–1.59.32.59)0.55 (0.24–1.24.24.24)0.15High fasting blood glucose Crude11.27 (0.72–2.22.72.22)1.53 (0.92–2.56.92.56)0.10 Fully-adjusted model210.99 (0.50–1.93.50.93)1.00 (0.52–1.93.52.93)0.98High triglyceride Crude11.12 (0.72–1.74.72.74)0.68 (0.44–1.04.44.04)0.08 Fully-adjusted model211.00 (0.59–1.68.59.68)0.56 (0.33–0.96.33.96)0.04Low HDL-c Crude10.92 (0.45–1.85.45.85)1.21 (0.65–2.24.65.24)0.53 Fully-adjusted model210.69 (0.29–1.64.29.64)1.41 (0.66–3.02.66.02)0.37High HOMA-IR Crude10.68 (0.32–1.43.32.43)0.79 (0.41–1.53.41.53)0.48 Fully-adjusted model210.70 (0.31–1.59.31.59)0.80 (0.36–1.79.36.79)0.58High blood pressure Crude11.34 (0.86–2.07.86.07)1.79 (1.19–2.69.19.69)0.01 Fully-adjusted model211.07 (0.62–1.84.62.84)1.57 (0.92–2.68.92.68)0.10 1All values are odds ratios and 95% confidence intervals2Fully-adjusted model: Adjusted for age, sex, total energy intake, physical activity, smoking, marital status, educational status, socioeconomic status, BMI Multivariable adjusted odds ratio (OR) and 95% confidence interval (CI) for metabolic components across tertiles of DRRD score1 1All values are odds ratios and 95% confidence intervals 2Fully-adjusted model: Adjusted for age, sex, total energy intake, physical activity, smoking, marital status, educational status, socioeconomic status, BMI Multivariable-adjusted mean ± SE for BDNF levels across tertiles of DRRD score are shown in Fig. 1. Despite a slight observed increase in BDNF values in tertile 3 vs. 1 of DRRD score, after adjusting for confounding factors such as age, sex, physical activity, having high blood pressure, high triglycerides, and high fasting blood glucose, there was no significant difference in BDNF levels among individuals in different DRRD score tertiles. Fig. 1Multivariable-adjusted mean ± SE for BDNF levels across tertiles of DRRD score. Model 1: Adjusted for age and sex; Model 2: More adjustments for physical activity, having high blood pressure, high triglycerides, and high fasting blood glucose. Values are Mean\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:\text{S}\text{E}$$\end{document}. P-values in crude models were obtained from one-way ANOVA, and in the adjusted model were obtained from ANCOVA. Non-significance indicates that none of the means are significantly different from another Multivariable-adjusted mean ± SE for BDNF levels across tertiles of DRRD score. Model 1: Adjusted for age and sex; Model 2: More adjustments for physical activity, having high blood pressure, high triglycerides, and high fasting blood glucose. Values are Mean\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\pm\:\text{S}\text{E}$$\end{document}. P-values in crude models were obtained from one-way ANOVA, and in the adjusted model were obtained from ANCOVA. Non-significance indicates that none of the means are significantly different from another Figure 2 represents the multivariable-adjusted mean ± SE for adropin levels across tertiles of DRRD score. After control of potential confounding variables such as age, sex, energy intake, physical activity, and BMI, no statistically significant differences were found in serum adropin levels across tertiles of DRRD score. Fig. 2Multivariable-adjusted mean ± SE for adropin levels across tertiles of DRRD score. Model 1: Adjusted for age, sex, and energy intake; Model 2: More adjustments for physical activity and BMI. Values are Mean ± SE. P-values in crude models were obtained from one-way ANOVA, and in the adjusted model were obtained from ANCOVA. Non-significance indicates that none of the means are significantly different from another Multivariable-adjusted mean ± SE for adropin levels across tertiles of DRRD score. Model 1: Adjusted for age, sex, and energy intake; Model 2: More adjustments for physical activity and BMI. Values are Mean ± SE. P-values in crude models were obtained from one-way ANOVA, and in the adjusted model were obtained from ANCOVA. Non-significance indicates that none of the means are significantly different from another Discussion This cross-sectional study showed that over 40% of Iranians had an MU phenotype and showed that adherence to the DRRD score was not associated with the odds of MU. However, individuals in the highest category of DRRD score adherence had a lower chance of hypertriglyceridemia than those in the lowest category. No substantial differences were observed in BDNF and adropin levels across DRRD score categories. Following the DRRD score may result in a decrease in TG levels, which is one of the components of MU, in individuals. The consumption of more fiber from cereals, which is part of the DRRD score, may help reduce TG by slowing sugar absorption. Additionally, more consumption of low glycemic index fruits can help control sugar levels and reduce TG. Reducing consumption of high glycemic index foods and sweetened beverages can help reduce TG, as well. In addition, reducing consumption of red and processed meats, which usually contain saturated fats, can reduce TG. Therefore, recommending such a dietary pattern may play a role in reducing TG levels in adults. To the best of our knowledge, due to a lack of information, this report is the first observational study that examined the association between DRRD score and metabolic health, serum BDNF, and adropin status in Iranian adults. A cross-sectional study conducted on Iranian adolescents indicated that higher adherence to DRRD can lead to improvements in high fasting blood glucose, high triglyceride, and high HOMA-IR, which are components of MU [39]. However, a prospective, population-based cohort study by Mirmiran et al. examined the association of the DDRRS and its components with MetS incidence in Iranian adults and observed a significant improvement in MetS, central obesity, and elevated blood pressure; however, they found no significant association with high blood sugar, high triglycerides, or low HDL-c [21]. A randomized clinical trial study investigating the effect of the Mediterranean diet on plasma BDNF levels in Spain adults reported that adherence to the Mediterranean diet was associated with improved plasma BDNF concentrations in depressed individuals [40]. A study conducted on American individuals that examined the effect of dietary interventions affecting glucose and lipid metabolism on plasma adropin concentrations stated that fructose consumption in individuals with hypertriglyceridemia, as well as dietary fat intake, can cause an increase in plasma adropin concentrations [41]. Additionally, data collected from three American cohort studies showed that adherence to DRRD can reduce the risk of chronic diseases like cardiovascular diseases, type II diabetes, and cancer [42]. The results of a cross-sectional study conducted on Iranian communities showed a marginally significant positive effect of adherence to the DDRRS on type II diabetes [13], although in our study, we did not observe a significant reduction in fasting blood glucose levels with more adherence to DRRD. Another investigation on Iranian participants found an effective association between DDRRs and chronic kidney disease (CKD) [12]. However, no association between DDRR and CVD was found in another cross-sectional study conducted on Iranian society [18]. In another cross-sectional study among Iranian populations, there was a positive association between adherence to the Diabetes Risk Reduction Score (DRRS) and a lower prevalence of hypertension, a component of MetS, in obese individuals. However, there was no significant association with hyperglycemia [20]. Several cross-sectional and cohort studies have been carried out in Italian and American communities on the linkage between DRRD adherence and various cancer types, such as breast cancer, colorectal cancer, and liver cancer; greater adherence to DRRD showed inverse associations with these types of cancers [33–44]. Limited data exist on the role of emerging biomarkers like BDNF and adropin in relation to specialized dietary patterns in Iranian adults. This study addresses this gap by focusing on these biomarkers and employing a specialized dietary score (DRRD), thereby contributing to a better understanding of the biological mechanisms linking diet and metabolic health, despite some non-significant findings. The implications for adult metabolic health include the potential for developing targeted dietary interventions to prevent MU in at-risk populations. From a policy perspective, these findings highlight the importance of educational programs to promote healthy dietary choices, particularly in professional settings like schools. However, further studies in more diverse populations are needed to validate these findings and broaden their applicability. In the present study, we utilized N4 software to extract dietary intakes of individuals from their FFQs. This software is based on the U.S. Department of Agriculture (USDA) food database, and complete information on some Iranian food items, such as fiber and trans-fat, is not available in this software. For example, the amount of trans-fat used in a candy in the US region may differ from that in Iran; this point might lead to a bias in the results. In addition, it is possible that the effects of DRRD score on some indicators of MH, such as blood pressure, hs-CRP, or HOMA-IR, will only become apparent after several years. Therefore, designing long-term cohort studies with large sample sizes can help to express more accurate results. We found a significant linkage between DRRD and hypertriglyceridemia (but not with other 5 components of metabolic unhealthy), while Mirmiran et al. have reported significant relations between DRRDS and MetS, abdominal obesity, and high blood pressure (but not with other 3 components of MetS) [21]. Several factors might contribute to these different findings. First, metabolic health with 6 components as the outcome in the present study was somewhat different from MetS with 5 components in the study of Mirmiran et al. Also, DRRD (as the exposure) in the present investigation had 9 components, while DRRDS in the mentioned cohort had 8 components. Second, the relatively small sample size of the present study might have limited the statistical power to detect significant associations, particularly compared to Mirmiran et al., which was conducted on a larger population of general Iranian adults (n = 3561). Third, demographic and methodological differences, such as the focus of the present study on relatively highly educated participants compared to the general population, might have influenced the differences in results. Furthermore, although no significant association was observed between adherence to the DRRD score and MU in the current analysis, the CI was in the relatively wide range of 0.58–1.70, indicating uncertainty that should be considered in the impact of the findings. We recommend that future studies employ larger sample sizes and more diverse populations to address these limitations. The lack of significant associations between DRRD score and serum BDNF or adropin levels in the current study might stem from the complex biological regulation of these biomarkers, influenced by factors like stress [45], which were not fully adjusted. Also, the small sample size and cross-sectional design might have limited the detection of significant associations. The inverse association of DRRD score with hypertriglyceridemia can be explained by several possible mechanisms. Reducing the consumption of simple sugars and refined carbohydrates leads to a decrease in lipogenesis, followed by a decrease in lipogenic enzymes such as acetyl-CoA carboxylase, and finally a decrease in TG level [46]. In addition, due to being rich in unsaturated fats, the DRRD score can increase the activity of the lipoprotein lipase (LPL) enzyme, which plays a role in the breakdown of TG [47, 48]. The next possible mechanism can also be justified by improving insulin sensitivity and controlling fats released from tissues, so improving insulin sensitivity leads to inhibition of lipolysis in adipose tissue and reduction of free fatty acids in the bloodstream, which reduces the production of TG in the liver [49]. In addition, anti-inflammatory foods in the DRRD score, such as fresh fruits, can reduce the expression of inflammatory cytokines such as TNF-α, thereby improving metabolic health [50, 51]. The current research has both limitations and strengths. This study was the first conducted to determine the association between DRRD score and metabolic health in an Iranian community. The study included individuals from diverse socioeconomic backgrounds working at schools and utilized validated questionnaires to collect data. However, due to higher educational levels and greater health awareness of the studied population, this population might not fully represent the broader or general population. Also, while outcomes were based on objective data, information on dietary intake and most confounding factors was self-reported, which may introduce recall bias in case of FFQ, potentially reducing the accuracy of dietary assessments. Additionally, the cross-sectional design of the study precludes establishing causality and assessing the temporality of associations between DRRD score and metabolic health outcomes, highlighting the need for prospective study designs in future research. Furthermore, due to budget constraints, it was not possible to calculate our sample size using biomarkers such as BDNF and adropin. Although adjustments were made for potential confounding variables, we acknowledge the possibility of residual confounders that may affect the validity of our results. Future studies should consider some issues. First, employing larger sample sizes could enhance statistical power to detect significant associations, particularly for biomarkers like BDNF and adropin, which may exhibit subtle changes in plasma levels. Second, including more diverse populations from different geographic regions, and cultural dietary patterns could improve the generalizability of findings. In conclusion, following the DRRD score dietary pattern could reduce hypertriglyceridemia, which is one of the metabolic unhealthy components, but no significant association was observed with other components of metabolic health. Adherence to DRRD score despite the increase in adropin was not associated with serum BDNF values. Recommendations to follow this dietary pattern may play a role in reducing TG levels in Iranian adults.